Mark Cuban online pharmacy to offer AbbVie Humira biosimilar
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
172,820€
-0,48%
Echtzeit-Aktienkurs Abbvie Inc.
Bid:
Ask:
Nachrichten zur Abbvie Inc. Aktie
AstraZeneca halts AbbVie-partnered bowel disease drug program
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie meets key goals for Rinvoq in mid-stage SLE trial
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie Says Upadacitinib 30 Mg Meets Primary Goals In SLE Patients In Mid-stage Study
WASHINGTON (dpa-AFX) - AbbVie Inc. (ABBV), a clinical-stage pharmaceutical company, Wednesday announced the results of its phase 2 SLEek study…
AbbVie Unusual Options Activity
read more...…
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what…
Should You Pick AbbVie Stock Over LLY?
Looking at stock returns, Eli Lilly has outperformed AbbVie and the broader indices....…
The Zacks Analyst Blog Highlights AbbVie, Intel, Qualcomm, Regeneron and CME Group
AbbVie, Intel, Qualcomm, Regeneron and CME Group are included in this Analyst Blog....…
Top Research Reports for AbbVie, Intel & Qualcomm
Todays Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), Intel Corporation (INTC) and Qualcomm…
AbbVie (ABBV) Gets FDA Nod for Lymphoma Drug Epcoritamab
The FDA approves AbbVies (ABBV) epcoritamab, to be marketed as Epkinly, for relapsed/refractory large B-cell lymphoma, a form of NHL.…
AbbVie, Genmab granted FDA nod for lymphoma therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie Gets FDA Expanded Nod for Rinvoq in Crohns Disease
AbbVie Gets FDA Expanded Nod for Rinvoq in Crohn's Disease...…
P/E Ratio Insights for AbbVie
read more...…
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what…
Allergan Aesthetics Says FDA Approves SKINVIVE By JUVEDERM
WASHINGTON (dpa-AFX) - Allergan Aesthetics, an AbbVie company (ABBV), announced Monday the U.S. FDA approval of SKINVIVE by JUVEDERM to…
AbbVie Says Health Canada Approves RINVOQ To Treat Adults With Active Nr-axSpA
OTTAWA (dpa-AFX) - AbbVie (ABBV) announced Tuesday that Health Canada has approved RINVOQ (upadacitinib, 15 mg), the first oral, once-daily…
AbbVie Rinvoq gets approval in Canada for expanded use in axial spondyloarthritis
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Looking for Steady, Passive Income? Buy AbbVie Stock
The drugmaker looks poised to rebound from its Humira loss of exclusivity....…
Form 10-Q AbbVie Inc. For: Mar 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
2 Things About AbbVie That Investors Are Ignoring
AbbVie shares slipped following the latest earnings report....…
Vertex Pharmaceuticals Stock Is an Even Better Buy Now Thanks to AbbVie
One big drugmakers pain translates into another big drugmakers gain....…
AbbVie, Bristol Myers Vied for Prometheus Before Merck Bought It
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Where Will AbbVie Be in 5 Years?
AbbVie has been a strong performer since its split from Abbott Labs, and its trying hard to keep the momentum…
AbbVie Stock Plunged: Should You Buy the Dip?
Last weeks sell-off appears to have been overdone....…
Pfizer, GSK, AbbVie among pharmas set to rise with May catalysts
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie (ABBV) Q1 2023 Earnings Call Transcript
ABBV earnings call for the period ending March 31, 2023....…
Insiderhandel: SVP, US COMMERCIAL OPERATIONS verkauft Aktien von AbbVie im Wert von 1.011.450$
Sorg, Elaine K. - Vorstand - Tag der Transaktion: 2023-04-25...…
Why did AbbVie stock fall today? Lower than expected EPS, sales
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why AbbVie Stock Is Crashing Today
AbbVies 2023 Q1 report isnt sitting well with shareholders today....…
AbbVie (ABBV) Q1 Earnings Beat, Skyrizi Sales Underperform
AbbVies (ABBV) first-quarter 2023 earnings and sales beat estimates. However, share price dives as some key drugs miss sales estimates....…
AbbVie Stock Falls as Humira Sales Drop
First-quarter sales for the anti-inflammatory drug fell 25% from a year ago on a reported basis....…
Vertex gains as AbbVie ends cystic fibrosis development program
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie: Enttäuschend in das neue Jahr - Aktienanalyse
Wien (www.aktiencheck.de) - AbbVie-Aktienanalyse von der Raiffeisen Bank International AG:
Benedikt-Luka Antic, Analyst der Raiffeisen Bank International AG (RBI), nimmt in…
AbbVie (ABBV) Q1 Earnings and Revenues Top Estimates
AbbVie (ABBV) delivered earnings and revenue surprises of 0.82% and 1.17%, respectively, for the quarter ended March 2023. Do the…
AbbVie Q1 Profit Drops, Inline With Estimates
WASHINGTON (dpa-AFX) - AbbVie (ABBV) reported earnings for first quarter that decreased from last year in line with the Street…
AbbVie falls as key drugs underperform amid Humira patent cliff
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie stock falls toward a 6-week low after adjusted profit fell short of expectations, but the full-year outlook was raised
Shares of AbbVie Inc. ABBV dove 6.2% toward a six-week low in premarket trading Thursday, after the biopharmaceutical company missed…